UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tu2077 Effect of Daikenchuto, TU-100, on Gastrointestinal and Colonic Transit, Rectal and Anorectal Function in Female Patients With Functional Constipation

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-921-S-922

2013

Volltextzugriff (PDF)

Elobixibat for the treatment of constipation

Expert opinion on investigational drugs, 2013-02, Vol.22 (2), p.277-284

2013

Volltextzugriff (PDF)

Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea

Clinical gastroenterology and hepatology, 2012-09, Vol.10 (9), p.1009-1015.e3

2012

Volltextzugriff (PDF)

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome

American journal of physiology: Gastrointestinal and liver physiology, 2012-07, Vol.303 (1), p.G120-G128

2012

Volltextzugriff (PDF)

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome

American journal of physiology: Gastrointestinal and liver physiology, 2012-07, Vol.302 (13), p.G120

2012

Volltextzugriff (PDF)

Tu1419 Relationship of Synthesis and Fecal Excretion of Bile Acids to Fecal Fat and Weight, and Genetic Variations in Bile Acid Regulatory Pathways in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Constipation (IBS-C)

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-827-S-827

2012

Volltextzugriff (PDF)

755 Effect of ROSE-010 on Gastrointestinal Motor Functions in Female Patients With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-132-S-133

2012

Volltextzugriff (PDF)

Pharmacogenetics of the Effects of Colesevelam on Colonic Transit in Irritable Bowel Syndrome with Diarrhea

Digestive diseases and sciences, 2012-05, Vol.57 (5), p.1222-1226

2012

Volltextzugriff (PDF)

Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea

Neurogastroenterology and motility, 2012-04, Vol.24 (4), p.358-e169

2012

Volltextzugriff (PDF)

Engaging the human in the design of residential energy reduction applications

2012 International Conference on Collaboration Technologies and Systems (CTS), 2012, p.338-344

2012

Volltextzugriff (PDF)

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome

American journal of physiology: Gastrointestinal and liver physiology, 2012, Vol.66 (1)

2012

Volltextzugriff (PDF)

Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation

The American journal of gastroenterology, 2011-12, Vol.106 (12), p.2154-2164

2011

Volltextzugriff (PDF)

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls

American journal of physiology: Gastrointestinal and liver physiology, 2011-11, Vol.301 (5), p.G919-G928

2011

Volltextzugriff (PDF)

Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome

Gastroenterology (New York, N.Y. 1943), 2011-11, Vol.141 (5), p.1638-1647.e7

2011

Volltextzugriff (PDF)

Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders

Neurogastroenterology and motility, 2011-11, Vol.23 (11), p.995-e458

2011

Volltextzugriff (PDF)

Effects of Dronabinol, a Non-Selective Cannabinoid Receptor Agonist, on Gastrointestinal and Colonic Transit in Diarrhea-Predominant Irritable Bowel Syndrome: 1339

The American journal of gastroenterology, 2011-10, Vol.106, p.S513

2011

Volltextzugriff (PDF)

Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome

Gastroenterology (New York, N.Y. 1943), 2011-07, Vol.141 (5), p.1638-1647.e7

2011

Volltextzugriff (PDF)

A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With Diarrhea

Gastroenterology (New York, N.Y. 1943), 2011-06, Vol.140 (7), p.1934-1942

2011

Volltextzugriff (PDF)

Lubiprostone for the treatment of opioid-induced bowel dysfunction

Expert opinion on pharmacotherapy, 2011-04, Vol.12 (6), p.983-990

2011

Volltextzugriff (PDF)

Pharmacogenetics of the Effects of Colesevelam on Colonic Transit in Irritable Bowel Syndrome With Diarrhea

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-524-S-525

2011

Volltextzugriff (PDF)

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls

American journal of physiology: Gastrointestinal and liver physiology, 2011, Vol.64 (5)

2011

Volltextzugriff (PDF)

Pharmacodynamic Effects of Dronabinol, a Non-Selective Cannabinoid Receptor Agonist, on Colonic Sensory and Motor Functions in Irritable Bowel Syndrome

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-2-S-2

2011

Volltextzugriff (PDF)

Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Patients with Functional Constipation

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-146-S-147

2011

Volltextzugriff (PDF)

Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis

Gastroenterology (New York, N.Y. 1943), 2010-11, Vol.139 (5), p.1549-1558.e1

2010

Volltextzugriff (PDF)

Emerging Pharmacologic Therapies for Irritable Bowel Syndrome

Current gastroenterology reports, 2010-10, Vol.12 (5), p.408-416

2010

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(44)
Tagungsberichte
(1)

Sprache

Englisch
(45)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Adult
(14)
Gastroenterology & Hepatology
(14)
Gastroenterology And Hepatology
(14)
Female
(12)
Middle Aged
(12)
Male
(8)
Biological And Medical Sciences
(7)
Colon
(6)
Colon - Physiopathology
(6)
Constipation
(6)
Double-Blind Method
(6)
Gastrointestinal Transit - Drug Effects
(6)
Irritable Bowel Syndrome - Drug Therapy
(6)
Medical Sciences
(6)
Animals
(5)
Diarrhea
(5)
Diarrhea - Physiopathology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tu2077 Effect of Daikenchuto, TU-100, on Gastrointestinal and Colonic Transit, Rectal and Anorectal Function in Female Patients With Functional Constipation

Elobixibat for the treatment of constipation

Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome

Tu1419 Relationship of Synthesis and Fecal Excretion of Bile Acids to Fecal Fat and Weight, and Genetic Variations in Bile Acid Regulatory Pathways in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Constipation (IBS-C)

755 Effect of ROSE-010 on Gastrointestinal Motor Functions in Female Patients With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Pharmacogenetics of the Effects of Colesevelam on Colonic Transit in Irritable Bowel Syndrome with Diarrhea

Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea

Engaging the human in the design of residential energy reduction applications

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome

Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls

Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome

Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders

Effects of Dronabinol, a Non-Selective Cannabinoid Receptor Agonist, on Gastrointestinal and Colonic Transit in Diarrhea-Predominant Irritable Bowel Syndrome: 1339

Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome

A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With Diarrhea

Lubiprostone for the treatment of opioid-induced bowel dysfunction

Pharmacogenetics of the Effects of Colesevelam on Colonic Transit in Irritable Bowel Syndrome With Diarrhea

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls

Pharmacodynamic Effects of Dronabinol, a Non-Selective Cannabinoid Receptor Agonist, on Colonic Sensory and Motor Functions in Irritable Bowel Syndrome

Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Patients with Functional Constipation

Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis

Emerging Pharmacologic Therapies for Irritable Bowel Syndrome

Suchergebnisse filtern